Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Assessment of Wrist Joint and Knee Joint Inflammation in Patients With Rheumatoid Arthritis by Quantitative Three Dimensional Power Doppler Ultrasonography
This completed clinical trial evaluated inflammation in the wrist and knee joints of rheumatoid arthritis patients using quantitative three-…
-
CLINICAL_TRIALS trial_result · 2015-02-06Clinical Trial Update: A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs [Phase 4]
A Phase 4 trial evaluated adding tocilizumab to non-biologic DMARDs in adults with moderate-to-severe rheumatoid arthritis who had an inadeq…
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis [Phase 3]
Phase 3 study evaluating ultrasound scores as an indicator of response to subcutaneous abatacept in rheumatoid arthritis; results have been …
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Rheumatoid Arthritis Through Education and US Study (RAEUS) [NA]
A completed clinical trial named RAEUS investigating education-based interventions for rheumatoid arthritis, sponsored by National Universit…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation [Phase 4]
Phase 4 trial update shows tocilizumab can induce remission in rheumatoid arthritis and may maintain efficacy after discontinuation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-20FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE) [Phase 4]
Phase 4 trial ACT-ALONE evaluated reducing systemic methylprednisolone in rheumatoid arthritis patients receiving background tocilizumab (Ac…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA) [NA]
This clinical trial evaluated how oral and intestinal microbiota may influence rheumatoid arthritis and related conditions, with results pos…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial results evaluating tocilizumab for reducing signs and symptoms in patients with rheumatoid arthritis are reported.
-
CLINICAL_TRIALS trial_result · 2014-12-24Clinical Trial Update: A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate [Phase 2]
Phase 2 randomized study evaluating combination therapy with Rituximab (MabThera) and Tocilizumab (RoActemra) versus Tocilizumab alone in rh…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis [Phase 1]
Phase 1 safety study of PRTX-100 combined with methotrexate or leflunomide for active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis [Phase 1]
Phase 1 study evaluating the safety and tolerability of NNC0141-0000-0100 in subjects with rheumatoid arthritis has completed.
-
FDA approval · 2014-12-19FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for SIMPONI (golimumab) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of subcutaneous ustekinumab (Stelara) with CNTO 1959 in patients with active rheumatoi…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Clinical Study of Xin'an Medicine in the Treatment of Bi Syndrome [NA]
Completed clinical trial evaluating Xin'an Medicine for rheumatoid arthritis (Bi Syndrome) conducted by The First Affiliated Hospital of Anh…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease [NA]
A completed clinical trial evaluated the effects of interleukin-1 inhibition on vascular function and left ventricular function in patients …
-
CLINICAL_TRIALS research · 2014-12-03Clinical Trial Update: Can Creatine Supplementation Improve Body Composition and Physical Function in Rheumatoid Arthritis Patients? [NA]
A clinical trial update investigates whether creatine supplementation can improve body composition and physical function in patients with rh…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study [Phase 4]
Phase 4 trial comparing leflunomide with sulfasalazine/methotrexate in rheumatoid arthritis was terminated; ultrasound and MRI were used for…
-
CLINICAL_TRIALS research · 2014-12-02Clinical Trial Update: Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)
This update reports the completion of the Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (T…
-
FDA approval · 2014-11-28FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA supplemental approval for a diclofenac sodium product manufactured by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept [Phase 3]
Phase 3 trial evaluating the ability of subjects with rheumatoid arthritis or psoriatic arthritis to effectively use a reusable autoinjector…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids [Phase 4]
Phase 4 clinical trial updates on the efficacy of monthly ibandronate in women with rheumatoid arthritis and reduced bone mineral density on…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: The Predictive Value of Ultrasound in Early Rheumatoid Arthritis
The completed trial evaluated whether ultrasound findings can predict progression or outcomes in patients with early rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial update evaluating milnacipran for widespread, non-joint pain in rheumatoid arthritis; the trial has completed and res…
-
FDA approval · 2014-11-14FDA Approved: ARAVA — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA document concerns a supplemental application for ARAVA (leflunomide) by Sanofi-Aventis U.S. LLC, indicating a supplemental approval …